It has also been reported that disruption of toll-like receptor 4 (TLR4)/EGFR signaling pathway reduced inflammatory activity and foam cell formation, resulting in alleviating atherosclerosis (Wang et al. 2017). This evidence concerns the gene TLR4 and atherosclerosis.